Table 2.

Change in PSS and CFS (all participants; estimated marginal means).

	Ashwagandha (n = 60)					Placebo (n = 60)					p-Value b	Percentage change: Week 0 to week 12
	Week 0	Week 4	Week 8	Week 12	p-Value a	Week 0	Week 4	Week 8	Week 12	p-Value a		Ashwagandha	Placebo
PSS (total score)
Mean	19.80	15.35	14.00	12.16	<0.001	19.73	15.16	14.41	12.70	<0.001	0.867	−38.59	−35.63
SE	0.56	0.82	0.81	0.85		0.56	0.75	0.73	0.74
CFS (total score)
Mean	16.81	11.72	11.25	9.11	<0.001	16.85	11.43	12.49	11.55	<0.001	0.016	−45.81	−31.45
SE	0.58	0.74	0.73	0.65		0.56	0.55	0.73	0.76

Results (estimated means) are generated from generalized mixed-effects models adjusted for age and BMI.

^ap-Values are generated from repeated measures generalized mixed-effects models adjusted for age and BMI (time effects baseline, week 4, 8, and 12).

^bp-Values are generated from repeated measures generalized mixed-effects models adjusted for age and BMI (time × group interaction).